mRNA-based HIV-1 vaccines
S Ahmed, A Herschhorn - Clinical microbiology reviews, 2024 - journals.asm.org
The success of the Severe Acute Respiratory Syndrome Coronavirus 2 mRNA vaccines to
lessen/prevent severe COVID-19 opened new opportunities to develop RNA vaccines to …
lessen/prevent severe COVID-19 opened new opportunities to develop RNA vaccines to …
Experimental models for HIV latency and molecular tools for reservoir quantification—an update
D Angamuthu, S Vivekanandan… - Clinical Microbiology …, 2023 - Am Soc Microbiol
SUMMARY A major impediment for HIV cure is the ability of the virus to integrate its genome
in the form of replication-competent proviral DNA into the cellular genome of the host and …
in the form of replication-competent proviral DNA into the cellular genome of the host and …
Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies
D Parthasarathy, KR Pothula, S Ratnapriya… - Nature …, 2024 - nature.com
Abstract HIV-1 envelope glycoproteins (Envs) of most primary HIV-1 strains exist in closed
conformation and infrequently sample open states, limiting access to internal epitopes. Thus …
conformation and infrequently sample open states, limiting access to internal epitopes. Thus …
HIResist: a database of HIV-1 resistance to broadly neutralizing antibodies
Motivation Changing the course of the human immunodeficiency virus type I (HIV-1)
pandemic is a high public health priority with approximately 39 million people currently living …
pandemic is a high public health priority with approximately 39 million people currently living …
An HIV-1 CRISPR-Cas9 membrane trafficking screen reveals a role for PICALM intersecting endolysosomes and immunity
HIV-1 hijacks host proteins involved in membrane trafficking, endocytosis, and autophagy
that are critical for virus replication. Molecular details are lacking but are essential to inform …
that are critical for virus replication. Molecular details are lacking but are essential to inform …
MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells
Activated-to-memory transitioning CD4+ T cells display elevated expression of the HIV-1 co-
receptor CCR5 and are more prone to HIV-1 latent infection. Here, we show that p53 …
receptor CCR5 and are more prone to HIV-1 latent infection. Here, we show that p53 …
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivo
VC Jiménez, A Geretz, A Tokarev, PK Ehrenberg… - Iscience, 2023 - cell.com
Persistent HIV-1 reservoirs of infected CD4 T cells are a major barrier to HIV-1 cure,
although the mechanisms by which they are established and maintained in vivo remain …
although the mechanisms by which they are established and maintained in vivo remain …
Alternative substitutions of N332 in HIV-1AD8 gp120 differentially affect envelope glycoprotein function and viral sensitivity to broadly neutralizing antibodies targeting …
The envelope glycoprotein (Env) trimer on the surface of human immunodeficiency virus
type I (HIV-1) mediates viral entry into host CD4+ T cells and is the sole target of neutralizing …
type I (HIV-1) mediates viral entry into host CD4+ T cells and is the sole target of neutralizing …
Two-photon fluorescence lifetime imaging microscopy of NADH metabolism in HIV-1 infected cells and tissues
Rapid detection of microbial-induced cellular changes during the course of an infection is
critical to understanding pathogenesis and immunological homeostasis. In the last two …
critical to understanding pathogenesis and immunological homeostasis. In the last two …
Broad tricyclic ring inhibitors block SARS-CoV-2 spike function required for viral entry
S Ratnapriya, AR Braun, H Cervera Benet… - ACS infectious …, 2022 - ACS Publications
The entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells
requires binding of the viral spike glycoprotein to the angiotensin-converting enzyme 2 …
requires binding of the viral spike glycoprotein to the angiotensin-converting enzyme 2 …